生命科学资讯

Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo

Reed Jobs' cancer biotech investment firm Yosemite eyes $350M fund

AstraZeneca pays $1.2B for CSPC's long-acting obesity drugs

Takeda 'anticipated' Medicare negotiations for top seller Entyvio

Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says

White House postpones planned TrumpRx launch event

Sanofi vows to stay committed to vaccines as portfolio takes a hit

The disrupted fate of pharmacy startups

Sanofi's pipeline cuts; Breakthru Medicine raises $60M

Summit gets November PDUFA date for its PD-1xVEGF bispecific

Trump looks to raise South Korea levies; Siegfried expands

Agomab anticipates $182M IPO as it builds fibrosis pipeline

AstraZeneca makes $15B bet on China to expand manufacturing and R&D

Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff

Flagship's Repertoire gets another autoimmune partner in Lilly

Tenpoint gets FDA nod for presbyopia eye drop and $235M

ChenMed CEO warns against GLP-1s for seniors

Round three of IRA negotiations is expected to be ‘manageable’ for pharma

Oral Rogaine maker Veradermics looks to raise $181M from IPO

FDA asks court to pause Louisiana's abortion pill fight